000 | 01709 a2200505 4500 | ||
---|---|---|---|
005 | 20250514022454.0 | ||
264 | 0 | _c20020207 | |
008 | 200202s 0 0 eng d | ||
022 | _a0031-7144 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aŁazewska, D | |
245 | 0 | 0 |
_aPiperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length. _h[electronic resource] |
260 |
_bDie Pharmazie _cDec 2001 |
||
300 |
_a927-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarbamates _xchemical synthesis |
650 | 0 | 4 | _aChemical Phenomena |
650 | 0 | 4 | _aChemistry, Physical |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aHeart Atria _xdrug effects |
650 | 0 | 4 |
_aHistamine Antagonists _xchemical synthesis |
650 | 0 | 4 |
_aHistamine H1 Antagonists _xpharmacology |
650 | 0 | 4 |
_aHistamine H2 Antagonists _xpharmacology |
650 | 0 | 4 |
_aIleum _xdrug effects |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aIndicators and Reagents |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMuscarinic Antagonists _xpharmacology |
650 | 0 | 4 |
_aMuscle, Smooth _xdrug effects |
650 | 0 | 4 |
_aPiperidines _xchemical synthesis |
650 | 0 | 4 | _aReceptor, Muscarinic M3 |
650 | 0 | 4 |
_aReceptors, Histamine H3 _xdrug effects |
650 | 0 | 4 |
_aReceptors, Muscarinic _xdrug effects |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aKieć-Kononowicz, K | |
700 | 1 | _aPertz, H H | |
700 | 1 | _aStark, H | |
700 | 1 | _aSchunack, W | |
700 | 1 | _aElz, S | |
773 | 0 |
_tDie Pharmazie _gvol. 56 _gno. 12 _gp. 927-32 |
|
999 |
_c11713499 _d11713499 |